
CGEN
Healthcare · Biotechnology · $198.9M market cap
Next report
Before the open
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 1, 2027 · upcoming | Before the open | -0.07 | — | — |
| Nov 9, 2026 | Before the open | -0.08 | -0.06 | +25.0% |
| Aug 3, 2026 | Before the open | -0.07 | -0.07 | 0.0% |
| May 18, 2026 | Before the open | -0.08 | -0.08 | 0.0% |
| Mar 2, 2026 | Before the open | 0.14 | 0.60 | +328.6% |
| Nov 10, 2025 | Before the open | -0.09 | -0.07 | +22.2% |
| Aug 6, 2025 | Before the open | -0.08 | -0.08 | 0.0% |
| May 19, 2025 | Before the open | -0.06 | -0.08 | -33.3% |
| Mar 4, 2025 | Before the open | -0.07 | -0.07 | +6.7% |
| Nov 12, 2024 | Before the open | 0.21 | 0.01 | -95.2% |
| Aug 6, 2024 | Before the open | -0.05 | -0.02 | +60.0% |
| May 20, 2024 | Before the open | -0.11 | -0.08 | +27.3% |
| Mar 5, 2024 | Before the open | 0.23 | 0.11 | -52.2% |
| Nov 7, 2023 | Before the open | -0.12 | -0.11 |
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe. The company's pipeline consists of COM701, an immuno-oncology pipeline program with an anti-PVRIG antibody; COM902, a therapeutic anti-TIGIT antibody, are in Phase 1 clinical trials and have been…
| +8.3% |
| Aug 7, 2023 | Before the open | -0.12 | -0.11 | +8.3% |
| May 15, 2023 | Before the open | -0.11 | -0.11 | 0.0% |
| Feb 27, 2023 | Before the open | -0.14 | -0.04 | +71.4% |
| Nov 14, 2022 | Before the open | -0.13 | -0.14 | -7.7% |
| Aug 4, 2022 | Before the open | -0.12 | -0.11 | +8.3% |
| May 16, 2022 | Before the open | -0.12 | -0.11 | +8.3% |
| Feb 24, 2022 | Before the open | -0.12 | -0.10 | +16.7% |
| Nov 12, 2021 | Before the open | -0.13 | -0.07 | +46.2% |
| Jul 28, 2021 | Before the open | -0.13 | -0.11 | +15.4% |
| May 13, 2021 | Before the open | -0.13 | -0.12 | +7.7% |
| Feb 25, 2021 | Before the open | -0.10 | -0.10 | 0.0% |
| Nov 5, 2020 | Before the open | -0.08 | -0.09 | -12.5% |
| Jul 30, 2020 | Before the open | -0.10 | -0.08 | +20.0% |
| May 6, 2020 | Before the open | -0.10 | -0.10 | 0.0% |
| Feb 20, 2020 | Before the open | -0.11 | -0.10 | +9.1% |
| Nov 11, 2019 | Before the open | -0.10 | -0.10 | 0.0% |
| Aug 5, 2019 | Before the open | -0.13 | -0.10 | +23.1% |
| May 20, 2019 | Before the open | -0.16 | -0.14 | +12.5% |
| Feb 26, 2019 | Before the open | -0.18 | -0.16 | +11.1% |
| Nov 7, 2018 | Before the open | -0.15 | -0.05 | +66.7% |
| Aug 1, 2018 | Before the open | -0.19 | -0.19 | 0.0% |
| May 9, 2018 | Before the open | -0.19 | 0.00 | +101.1% |
| Feb 21, 2018 | Before the open | -0.20 | -0.18 | +10.0% |